182 related articles for article (PubMed ID: 12466128)
1. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.
Shen L; Liang AC; Lu L; Au WY; Kwong YL; Liang RH; Srivastava G
Am J Pathol; 2002 Dec; 161(6):2123-31. PubMed ID: 12466128
[TBL] [Abstract][Full Text] [Related]
2. Frequent mutations of Fas gene in nasal NK/T cell lymphoma.
Takakuwa T; Dong Z; Nakatsuka S; Kojya S; Harabuchi Y; Yang WI; Nagata S; Aozasa K
Oncogene; 2002 Jul; 21(30):4702-5. PubMed ID: 12096347
[TBL] [Abstract][Full Text] [Related]
3. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.
Lee SH; Shin MS; Park WS; Kim SY; Kim HS; Han JY; Park GS; Dong SM; Pi JH; Kim CS; Kim SH; Lee JY; Yoo NJ
Oncogene; 1999 Jun; 18(25):3754-60. PubMed ID: 10391683
[TBL] [Abstract][Full Text] [Related]
4. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
5. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G
Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
Li T; Zhang B; Ye Y; Yin H
Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
[TBL] [Abstract][Full Text] [Related]
7. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma.
Shin MS; Park WS; Kim SY; Kim HS; Kang SJ; Song KY; Park JY; Dong SM; Pi JH; Oh RR; Lee JY; Yoo NJ; Lee SH
Am J Pathol; 1999 Jun; 154(6):1785-91. PubMed ID: 10362803
[TBL] [Abstract][Full Text] [Related]
8. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
[TBL] [Abstract][Full Text] [Related]
11. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma.
Wohlfart S; Sebinger D; Gruber P; Buch J; Polgar D; Krupitza G; Rosner M; Hengstschläger M; Raderer M; Chott A; Müllauer L
Am J Pathol; 2004 Mar; 164(3):1081-9. PubMed ID: 14982861
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
13. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
[TBL] [Abstract][Full Text] [Related]
14. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
Cascino I; Papoff G; De Maria R; Testi R; Ruberti G
J Immunol; 1996 Jan; 156(1):13-7. PubMed ID: 8598453
[TBL] [Abstract][Full Text] [Related]
15. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.
Papoff G; Cascino I; Eramo A; Starace G; Lynch DH; Ruberti G
J Immunol; 1996 Jun; 156(12):4622-30. PubMed ID: 8648105
[TBL] [Abstract][Full Text] [Related]
16. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas.
Lee SH; Shin MS; Lee JY; Park WS; Kim SY; Jang JJ; Dong SM; Na EY; Kim CS; Kim SH; Yoo NJ
J Pathol; 1999 Jun; 188(2):207-12. PubMed ID: 10398166
[TBL] [Abstract][Full Text] [Related]
17. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
19. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
20. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
